4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · IEX Real-Time Price · USD
18.20
-8.55 (-31.96%)
At close: Jul 17, 2024, 4:00 PM
19.50
+1.30 (7.14%)
After-hours: Jul 17, 2024, 7:59 PM EDT

4D Molecular Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018
Cash & Equivalents
275.59249.1152.35153276.7349.65
Upgrade
Short-Term Investments
250.3239.12161.294.7800
Upgrade
Cash & Cash Equivalents
525.91288.23213.55247.78276.7349.65
Upgrade
Cash Growth
162.36%34.97%-13.81%-10.46%457.33%-45.89%
Upgrade
Receivables
0000.051.490.98
Upgrade
Other Current Assets
9.688.366.968.464.441.88
Upgrade
Total Current Assets
535.59296.59220.51256.28282.6652.51
Upgrade
Property, Plant & Equipment
30.5831.6735.3528.955.075.05
Upgrade
Long-Term Investments
62.9410.954.9167.6500
Upgrade
Other Long-Term Assets
0.770.681.080.60.60.68
Upgrade
Total Long-Term Assets
94.343.341.3497.215.685.73
Upgrade
Total Assets
629.88339.89261.85353.49288.3358.23
Upgrade
Accounts Payable
4.223.523.324.761.791.74
Upgrade
Deferred Revenue
1.321.251.965.0919.8119.47
Upgrade
Current Debt
3.173.152.661.2300
Upgrade
Other Current Liabilities
7.6911.047.795.25-4.86-8.26
Upgrade
Total Current Liabilities
16.418.9515.7316.3416.7412.96
Upgrade
Long-Term Debt
1111.5213.4715.2200
Upgrade
Other Long-Term Liabilities
1.921.591.312.8315.215.27
Upgrade
Total Long-Term Liabilities
12.9213.1114.7818.0415.215.27
Upgrade
Total Liabilities
29.3232.0630.5134.3831.9428.22
Upgrade
Total Debt
14.1714.6716.1216.4500
Upgrade
Debt Growth
-9.64%-9.01%-1.97%---
Upgrade
Retained Earnings
-447.73-415.33-314.49-207-135.68-79.03
Upgrade
Comprehensive Income
-0.110.02-1.2-0.4200
Upgrade
Shareholders' Equity
600.56307.83231.34319.11256.39-72.97
Upgrade
Net Cash / Debt
511.74273.56197.43231.33276.7349.65
Upgrade
Net Cash / Debt Growth
176.96%38.56%-14.65%-16.41%457.33%-45.89%
Upgrade
Net Cash Per Share
10.396.996.108.3443.039.66
Upgrade
Working Capital
519.19277.64204.78239.94265.9139.55
Upgrade
Book Value Per Share
12.197.877.1511.5139.87-14.19
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).